It has been reported to be downregulated in NSCLC [34], and its degradation accelerates lung tumor growth by upgrading interaction between the potent mitogen platelet-derived growth factor receptor (PDGFR) and phosphatidylinositol 3 kinase (PI3 K) [35]. The gene discussed is PDGFRB; the disease is non-small cell lung carcinoma.